Citation
(2008), "Drug-eluting stents in patients with bare-metal in-stent restenosis", Clinical Governance: An International Journal, Vol. 13 No. 3. https://doi.org/10.1108/cgij.2008.24813cae.007
Publisher
:Emerald Group Publishing Limited
Copyright © 2008, Emerald Group Publishing Limited
Drug-eluting stents in patients with bare-metal in-stent restenosis
Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 13, Issue 3
A. Dibra, A. Kastrati, F. Alfonso, M. Seyfarth, M.J. Perez-Vizcayno, J. Mehilli, and A. Schomig, (2007), “Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials”
Journal of the American College of CardiologyVol. 49 No. 5pp. 616-23
This review concluded that sirolimus- and paclitaxel-eluting stents were associated with a significantly lower likelihood of target lesion revascularisation relative to conventional techniques (balloon angioplasty or vascular brachytherapy). This review was generally well-conducted and its conclusions seem reliable.